Jove
Visualize
お問い合わせ

関連する概念動画

Drug Product Stability01:16

Drug Product Stability

223
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
223
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

177
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
177
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

193
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
193
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

397
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
397
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

199
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
199

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunity.

bioRxiv : the preprint server for biology·2026
Same author

Retail cattle meat as a reservoir of multidrug-resistant Salmonella harboring β-lactamase genes in Sylhet, Bangladesh.

Veterinary research communications·2026
Same author

Impact of Low-Dose Cranberry Polyphenols on Gut Microbiota and Circulating Polyphenol Metabolites in Overweight and Obese Individuals (A Randomized Double-Blind Placebo-Controlled Clinical Pilot Study).

Food science & nutrition·2026
Same author

Antibiofilm Mechanisms and Applications of Natural Compounds.

Journal of food protection·2026
Same author

A Multidisciplinary Review of the Microbial, Functional, and Consumer Advancement of Indian Lassi.

Probiotics and antimicrobial proteins·2026
Same author

Fertile field emission response in scrambled SmNiO<sub>3</sub> nanopins.

Scientific reports·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

Updated: Jan 13, 2026

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
08:38

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Published on: September 10, 2016

25.1K

安定性と規制に関する考慮事項を中心としたプロバイオティクス開発戦略

Hye Kim1, Ariful Haque1, Abdur Razzak1

  • 1Department of Food Science and Technology, Texas A&M University, College Station, Texas, USA.

Comprehensive reviews in food science and food safety
|January 6, 2026
PubMed
まとめ

効果的なプロバイオティクスを開発するには、実験室での発見と産業界のニーズを橋渡しする必要があります。標準化された評価と規制の調和は、次世代プロバイオティクスを安全かつ効率的に商品化するための鍵となります。

キーワード:
マイクロカプセル化プロバイオティクス規制の枠組み安定性菌株開発

さらに関連する動画

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
05:45

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

4.2K
The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective
04:40

The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective

Published on: June 16, 2022

9.3K

関連する実験動画

Last Updated: Jan 13, 2026

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
08:38

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Published on: September 10, 2016

25.1K
Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
05:45

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

4.2K
The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective
04:40

The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective

Published on: June 16, 2022

9.3K

科学分野:

  • 微生物学およびバイオテクノロジー
  • 食品科学および技術
  • 規制科学

背景:

  • プロバイオティクス菌株の開発は、実験室での有効性を工業規模の安定性とパフォーマンスに移行する際の課題に直面しています。
  • 消費者の需要と健康上の利点は、プロバイオティクスにおける学術的および産業的な研究を大きく推進しています。
  • 実証された機能的結果と商品化の要件との間にはギャップがあり、市場参入を妨げています。

研究 の 目的:

  • 菌株のスクリーニングから規制の枠組みまでのプロバイオティクス開発パイプラインを批判的にレビューすること。
  • 生産ストレスがプロバイオティクス菌株の生存率に与える影響と、回復力を高める戦略の効果を調査すること。
  • 世界的な規制システムを比較し、調和の取れた評価フレームワークの必要性を強調すること。

主な方法:

  • プロバイオティクス菌株のスクリーニングと回復力戦略に関する研究の文献レビュー。
  • 菌株の生存率に対する生産ストレス（熱、酸素、消化）の分析。
  • 米国、EU、日本、韓国、中国の規制の枠組みの比較分析。

主要な成果:

  • 熱ショックやマイクロカプセル化などの適応戦略は、菌株の生存率に変動的な改善（それぞれ最大31倍および100倍）を示し、菌株の特異性と再現性の問題が浮き彫りになっています。
  • 生産ストレスはプロバイオティクスの生存率に大きな影響を与えるため、標的を絞った回復力戦略が必要です。
  • 分類、安全性、機能的根拠に関する世界的な規制のばらつきは、国際市場へのアクセスを複雑にしています。

結論:

  • 科学的検証、産業的パフォーマンス、規制遵守を統合した調和の取れた評価フレームワークは、次世代プロバイオティクスの開発に不可欠です。
  • プロバイオティクスの有効性、安全性、スケーラビリティ、経済的実行可能性のバランスの取れた進歩には、学界、産業界、規制当局間の継続的な協力が不可欠です。
  • プロバイオティクスの商品化ギャップを克服するには、標準化されたアプローチが必要です。